Schenkl, C.; Schrepper, A.; Heyne, E.; Doenst, T.; Schwarzer, M.
The IGF-1R Inhibitor NVP-AEW541 Causes Insulin-Independent and Reversible Cardiac Contractile Dysfunction. Biomedicines 2022, 10, 2022.
https://doi.org/10.3390/biomedicines10082022
AMA Style
Schenkl C, Schrepper A, Heyne E, Doenst T, Schwarzer M.
The IGF-1R Inhibitor NVP-AEW541 Causes Insulin-Independent and Reversible Cardiac Contractile Dysfunction. Biomedicines. 2022; 10(8):2022.
https://doi.org/10.3390/biomedicines10082022
Chicago/Turabian Style
Schenkl, Christina, Andrea Schrepper, Estelle Heyne, Torsten Doenst, and Michael Schwarzer.
2022. "The IGF-1R Inhibitor NVP-AEW541 Causes Insulin-Independent and Reversible Cardiac Contractile Dysfunction" Biomedicines 10, no. 8: 2022.
https://doi.org/10.3390/biomedicines10082022
APA Style
Schenkl, C., Schrepper, A., Heyne, E., Doenst, T., & Schwarzer, M.
(2022). The IGF-1R Inhibitor NVP-AEW541 Causes Insulin-Independent and Reversible Cardiac Contractile Dysfunction. Biomedicines, 10(8), 2022.
https://doi.org/10.3390/biomedicines10082022